Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 12,180 shares at $552.36 ($6.2M) on 2020-09-22, disclosed to the SEC on 2020-09-23.
Open-market sale of $6.2M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,000 | $0 | 0.0% |
| 2 | $552.36 | 1,000 | $552K | 8.9% |
| 3 | $552.36 | 5,090 | $2.8M | 45.5% |
| 4 | $552.36 | 5,090 | $2.8M | 45.5% |
| Total | $507.01 avg | 12,180 | $6.2M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |